101 related articles for article (PubMed ID: 7743273)
1. [Involvement of polyamines in malignant proliferative processes: antineoplastic effects of a polyamine deficiency].
Quemener V; Chamaillard L; Brachet P; Havouis R; Moulinoux JP
Bull Acad Natl Med; 1994 Nov; 178(8):1591-605; discussion 1606-8. PubMed ID: 7743273
[TBL] [Abstract][Full Text] [Related]
2. [The involvement of polyamines in the malignant proliferative process. The anticancer effect of polyamine deprivation].
Quemener V; Chamaillard L; Brachet P; Havouis R; Moulinoux JP
Ann Gastroenterol Hepatol (Paris); 1995; 31(3):181-8; discussion 188-9. PubMed ID: 7653990
[TBL] [Abstract][Full Text] [Related]
3. Polyamine deprivation: a new tool in cancer treatment.
Quemener V; Blanchard Y; Chamaillard L; Havouis R; Cipolla B; Moulinoux JP
Anticancer Res; 1994; 14(2A):443-8. PubMed ID: 8017845
[TBL] [Abstract][Full Text] [Related]
4. Neomycin inhibition of intestinal putrescine uptake.
Hardy A; Catros-Quemener V
Anticancer Res; 1998; 18(6A):4163-9. PubMed ID: 9891462
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth and polyamine uptake by tetracyclic amidines bearing a putrescine moiety.
Mens T; Tomasi S; Eifler-Lima VL; Uriac P; Huet J; Catros-Quemener V
Anticancer Res; 1997; 17(6D):4327-32. PubMed ID: 9494528
[TBL] [Abstract][Full Text] [Related]
6. Alterations in intestinal uptake of putrescine and tissue polyamine concentrations in tumor-bearing rats.
Brachet P; Quemener V; Havouis R; Tomé D; Moulinoux JP
Biochim Biophys Acta; 1994 Nov; 1227(3):161-70. PubMed ID: 7986823
[TBL] [Abstract][Full Text] [Related]
7. Polyamine deprivation stimulates natural killer cell activity in cancerous mice.
Chamaillard L; Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1993; 13(4):1027-33. PubMed ID: 8352521
[TBL] [Abstract][Full Text] [Related]
8. Polyamine deprivation enhances antitumoral efficacy of chemotherapy.
Quemener V; Moulinoux JP; Havouis R; Seiler N
Anticancer Res; 1992; 12(5):1447-53. PubMed ID: 1444206
[TBL] [Abstract][Full Text] [Related]
9. Alteration of intestinal putrescine uptake in tumour-bearing rats.
Desury G; Moulinoux JP; Delcros JG
Int J Oncol; 2002 Sep; 21(3):569-76. PubMed ID: 12168101
[TBL] [Abstract][Full Text] [Related]
10. Polyamine metabolism and polyamine excretion in normal and tumor bearing rodents.
Seiler N; Knödgen B; Bartholeyns J
Anticancer Res; 1985; 5(4):371-7. PubMed ID: 3929671
[TBL] [Abstract][Full Text] [Related]
11. In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
Cipolla B; Blanchard Y; Chamaillard L; Quemener V; Guillé F; Havouis R; Moulinoux JP
Urol Res; 1996; 24(2):93-8; discussion 99. PubMed ID: 8740978
[TBL] [Abstract][Full Text] [Related]
12. Effect of natural and synthetic polyamines on ethanol intake in UChB drinker rats.
Bilbeny N; Contreras S; Font M; Paeile C; García H
Alcohol; 2005 Jul; 36(3):169-77. PubMed ID: 16377458
[TBL] [Abstract][Full Text] [Related]
13. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis.
Fong LY; Pegg AE; Magee PN
Cancer Res; 1998 Dec; 58(23):5380-8. PubMed ID: 9850069
[TBL] [Abstract][Full Text] [Related]
14. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
Aziz SM; Gillespie MN; Crooks PA; Tofiq SF; Tsuboi CP; Olson JW; Gosland MP
J Pharmacol Exp Ther; 1996 Jul; 278(1):185-92. PubMed ID: 8764350
[TBL] [Abstract][Full Text] [Related]
15. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
16. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
17. The gastrointestinal tract as polyamine source for tumor growth.
Sarhan S; Knodgen B; Seiler N
Anticancer Res; 1989; 9(1):215-23. PubMed ID: 2495754
[TBL] [Abstract][Full Text] [Related]
18. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
19. [The effect of chemically modified polyamine analogs on polyamine and putrescine biosynthesis in a cell-free test system from a rat hepatoma].
Fedoronchuk TV; Siatkin SP; Lulle IZh; Ianson IaIa; Lidak MIu; Berezov TT
Biull Eksp Biol Med; 1993 Sep; 116(9):256-8. PubMed ID: 8117993
[TBL] [Abstract][Full Text] [Related]
20. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
